The Power of Product Portfolio: Why a Diverse Range Matters in PCD Pharma
In the competitive landscape of the PCD (Propaganda Cum Distribution) Pharma franchise business, a robust and diverse product portfolio is more
Blog, Pharma
Blog, Pharma
Partner with Us: Your Gateway to Success in the Pharmaceutical Industry
At  Sanctus Global, we are committed to building strong and mutually beneficial partnerships with our franchise associates. We believe in empowering our partners…
Blog, Pharma
Diving into the World of Pharmaceutical Product Manufacturing: A Comprehensive Guide
Before embarking on this journey, thorough market research is crucial. Identify the demand for specific pharmaceutical products, analyze competitor activity, and understand the prevailing market trends.
Blog, Pharma
What Are the Regulatory Requirements for Contract Manufacturing?
ontract manufacturing is a complex process that involves many different regulatory requirements.
Blog, Pharma
Adaptive Pharmaceutical Solutions for a Changing World
Sanctus Global Formulation, a leading pharmaceutical company in India, is at the forefront of this transformation, providing high-quality tablets and capsules
Blog, Pharma
Latest Trends & Insights in the PCD Pharma Industry
Pharmaceutical companies are investing heavily in research & development (R&D) to introduce advanced and effective medications. The demand for new
Blog, Pharma
Top Reasons to Partner with Sanctus Global Formulation for a Pharma Franchise
The Indian pharmaceutical industry ranks third globally in terms of volume and is expected to reach $65 billion by 2024 and $130 billion by 2030.
Blog, Pharma
Tips for Starting a Successful PCD Pharma Franchise in India
Sanctus Global Formulations Ltd is a leading name in the pharmaceutical industry, offering unmatched opportunities for entrepreneurs looking to start a PCD Pharma franchise.
Blog, Pharma
Future Trends in Contract Pharma Manufacturing: What to Expect in 2025 and Beyond
The global biologics market is expected to reach $600 billion by 2025. Contract manufacturers are increasing
Blog, Pharma
Third-Party Pharmaceutical Manufacturing: A Strategic Approach for Pharmaceutical Companies
The global pharmaceutical contract manufacturing market was valued at approximately $117.3 billion in 2021 and is projected to reach $171.2 billion